Privium Fund Management B.V.
- SEC CIK
- 0001795097
- Latest filing
- Aug 7, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Privium Fund Management B.V., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q2 2026)
- 234,222
- Value
- $19.1M
- % of portfolio
- 3.5%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 234,222 | $19.1M | 3.5% | −132,714−36.2% | Reduced | Holders |
| Q1 2026 | 366,936 | $23.0M | 4.8% | −31,268−7.9% | Reduced | Holders |
| Q4 2025 | 398,204 | $26.4M | 4.9% | −75,747−16.0% | Reduced | Holders |
| Q3 2025 | 473,951 | $16.3M | 2.9% | −138,263−22.6% | Reduced | Holders |
| Q2 2025 | 612,214 | $9.85M | 2.1% | −17,000−2.7% | Reduced | Holders |
| Q1 2025 | 629,214 | $8.02M | 2.1% | +248,628+65.3% | Added | Holders |
| Q4 2024 | 380,586 | $7.16M | 1.6% | +47,230+14.2% | Added | Holders |
| Q3 2024 | 333,356 | $6.46M | 1.6% | +46,420+16.2% | Added | Holders |
| Q2 2024 | 286,936 | $7.24M | 1.8% | +13,000+4.7% | Added | Holders |
| Q1 2024 | 273,936 | $7.83M | 2.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 273,936 | $8.49M | 2.4% | +14,900+5.8% | Added | Holders |
| Q3 2023 | 259,036 | $6.96M | 2.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 259,036 | $9.31M | 2.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 259,036 | $6.58M | 2.2% | +38,021+17.2% | Added | Holders |
| Q4 2022 | 221,015 | $8.87M | 3.4% | +45,622+26.0% | Added | Holders |
| Q3 2022 | 175,393 | $5.84M | 2.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 175,393 | $6.18M | 2.1% | −7,324−4.0% | Reduced | Holders |
| Q1 2022 | 182,717 | $8.40M | 1.9% | −21,676−10.6% | Reduced | Holders |
| Q4 2021 | 204,393 | $13.8M | 2.7% | – | No prior filing | Holders |